Description of bone marrow samples on which imprinting studies were performed
| Number . | Diagnosis . | Malignant cells (%) . | Sex/age (y) . | IGF-2 . | H19 . | SNRPN . | IGF-2R . | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DNA . | RNA . | DNA . | RNA . | DNA . | RNA . | DNA . | RNA . | ||||
| X12 | ALL in remission | < 5 | F38 | AB | ab | ||||||
| X22 | Normal | 0 | F73 | AB | ab | ||||||
| X26 | MGUS | 3 | M73 | AB | ab | ||||||
| X166 | Normal | 0 | M28 | AB | ab | AB | b | BC | bc | ||
| X175 | NHL staging | Involved | F45 | AB | ab | ||||||
| X177 | Normal | 0 | F30 | AB | ab | AB | a | AB | a | NI | |
| X178 | Normal | 0 | M35 | AB | ab | NI | NI | ||||
| X188 | T-ALL relapse | 28 | M4 | AB | ab | ||||||
| X196 | MDS:RA | NA | M59 | AB | ab | ||||||
| X221 | Megaloblastic | 0 | F80 | AB | ab | AB | b | AB | a | NI | |
| X279 | ALL | > 80 | F4 | AB | a | ||||||
| X289 | NHL staging | 0 | M45 | AB | ab | NI | |||||
| X293 | MPD | NA | M60 | AB | ab | NI | NI | ||||
| X296 | MDS:CMML | NA | M74 | AB | ab | AB | a | BC | bc | ||
| X369 | Neuroblastoma | Involved | M28 | AB | b | ||||||
| X374 | Normal | 0 | F74 | ni | AB | b | AB | a | AB | ab | |
| X381 | ITP | 0 | M88 | AB | ab | AB | a | NI | AC | ac | |
| X388 | Normal | 0 | F28 | AB | ab | AB | b | NI | NI | ||
| X391 | Iron deficiency | 0 | M60 | ni | AB | a | |||||
| X392 | MDS:RA | NA | M68 | ni | AB | a | |||||
| X393 | Rhabdomyoblastoma | ∼2 | M14 | AB | ab | ||||||
| X396 | MGUS | < 5 | M65 | AB | ab | NI | |||||
| X419 | Normal | 0 | F10 | AB | ab | AB | a | NI | BC | bc | |
| X610 | NHL-low grade | Involved | M70 | AB | b | ||||||
| Number . | Diagnosis . | Malignant cells (%) . | Sex/age (y) . | IGF-2 . | H19 . | SNRPN . | IGF-2R . | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DNA . | RNA . | DNA . | RNA . | DNA . | RNA . | DNA . | RNA . | ||||
| X12 | ALL in remission | < 5 | F38 | AB | ab | ||||||
| X22 | Normal | 0 | F73 | AB | ab | ||||||
| X26 | MGUS | 3 | M73 | AB | ab | ||||||
| X166 | Normal | 0 | M28 | AB | ab | AB | b | BC | bc | ||
| X175 | NHL staging | Involved | F45 | AB | ab | ||||||
| X177 | Normal | 0 | F30 | AB | ab | AB | a | AB | a | NI | |
| X178 | Normal | 0 | M35 | AB | ab | NI | NI | ||||
| X188 | T-ALL relapse | 28 | M4 | AB | ab | ||||||
| X196 | MDS:RA | NA | M59 | AB | ab | ||||||
| X221 | Megaloblastic | 0 | F80 | AB | ab | AB | b | AB | a | NI | |
| X279 | ALL | > 80 | F4 | AB | a | ||||||
| X289 | NHL staging | 0 | M45 | AB | ab | NI | |||||
| X293 | MPD | NA | M60 | AB | ab | NI | NI | ||||
| X296 | MDS:CMML | NA | M74 | AB | ab | AB | a | BC | bc | ||
| X369 | Neuroblastoma | Involved | M28 | AB | b | ||||||
| X374 | Normal | 0 | F74 | ni | AB | b | AB | a | AB | ab | |
| X381 | ITP | 0 | M88 | AB | ab | AB | a | NI | AC | ac | |
| X388 | Normal | 0 | F28 | AB | ab | AB | b | NI | NI | ||
| X391 | Iron deficiency | 0 | M60 | ni | AB | a | |||||
| X392 | MDS:RA | NA | M68 | ni | AB | a | |||||
| X393 | Rhabdomyoblastoma | ∼2 | M14 | AB | ab | ||||||
| X396 | MGUS | < 5 | M65 | AB | ab | NI | |||||
| X419 | Normal | 0 | F10 | AB | ab | AB | a | NI | BC | bc | |
| X610 | NHL-low grade | Involved | M70 | AB | b | ||||||
Columns labeled DNA refer to the genotype at a polymorphic site; columns labeled RNA indicate which alleles were expressed.
ALL indicates acute lymphoblastic leukemia; MGUS, monoclonal gammopathy of undetermined significance; NHL, non-Hodgkin lymphoma; MDS:RA, myelodysplasia:refractory anemia; MPD, myeloproliferative disease; ITP, immune thrombocytopenia; NA, not available.